Photo of Bishal Gyawali from ecancer.org
Jun 7, 2024, 12:00
Bishal Gyawali: Many thoughts on LAURA trial
Bishal Gyawali, Associate Professor at Queen’s University, shared a post on X/Twitter:
”Many thoughts on LAURA, will record it on ecancer video later. But the discussant of the LAURA trial basically said we now don’t need any RCTs even for other targeted therapies given these results? And no comment on the clear under staging of patients specially looking at the control arm curve? Doesn’t that make this more like treating metastatic disease early versus delayed? Which is also the reason for continued indefinite osi treatment.”
Source: Bishal Gyawali/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 13, 2024, 16:08
Nov 13, 2024, 16:02
Nov 13, 2024, 15:56
Nov 13, 2024, 15:46
Nov 13, 2024, 15:32
Nov 13, 2024, 15:29
Nov 13, 2024, 15:25